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1. Introduction  
In present stimulation protocols for IVF, some patients experience a rise in serum 
progesterone (P) concentration in the late follicular phase. Premature P rise affects about 5 to 
as high as 38% of IVF patients (Edelstein et al., 1990; Silverberg et al., 1991; Ubaldi et al., 
1996; Bosch et al., 2003) and is associated with lower implantation and pregnancy rates. It is 
defined as a rise in P concentration towards the end of the follicular phase above a certain 
threshold, which is set arbitrarily. There is an ongoing debate about the definition of 
premature luteinisation, or better defined as ‘premature progesterone rise’, as to which 
threshold for premature P rise should be established (Van Vaerenbergh et al., 2011; Labarta 
et al., 2011). Therefore, the changes in gene expression were studied in patients with 
premature progesterone rise. 
2. Research methods 
2.1 Patients 
This study was approved by the Ethics Committee of the University Hospital of the Vrije 
Universiteit Brussel. All patients signed an informed consent. The patients included in the 
study were women below 37 years of age who underwent a first or second treatment cycle 
of in-vitro fertilisation (IVF) with intracytoplasmic sperm injection (ICSI). Patients were 
excluded from the study if they requested preimplantation genetic diagnosis, had an 
azoospermic partner or  had a  serum follicle-stimulating hormone (FSH) level on day 3 of 
the menstrual cycle of more than 12 IU/L. A single embryo transfer policy was applied in all 
cycles. Patients with endometriosis ≥ stage III (AFS (American Fertility Society) 
classification), with PCOS (polycystic ovary syndrome; defined according to the Rotterdam 
2003 criteria, Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 
2004) or with any other endometrial pathology were excluded from the study. 
2.2 Stimulation protocol 
Ovarian stimulation was performed with a median starting dose of 200 IU rec-FSH (follicle 
stimulating hormone, Puregon®, MSD, Oss, The Netherlands), from day 2 until day 6 of the 
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cycle. From day 7 onwards, the dose was adjusted individually. To inhibit premature LH 
surge, daily GnRH-antagonist (Orgalutran® 0,25mg, MSD) was used from the morning of 
day 6 of stimulation. Final oocyte maturation was achieved by administration of 10 000 IU of 
hCG (human chorionic gonadotrophin, Pregnyl®, MSD) as soon as 3 (or more) follicles ≥ 17 
mm were present. Oocyte retrieval was carried out 36 hours after hCG administration. The 
luteal phase was supported with 600 mg micronized progesterone (Utrogestan®, Piette, 
Brussels, Belgium) (Figure 1). IVF and ICSI procedures have been described in detail 
elsewhere (Van Landuyt et al., 2005). 
Freshly ejaculated sperm was used. One or two embryos were transferred in the same cycle 
on day 3 or day 5 of embryo culture, according to the Belgian reimbursement law. Embryo 
quality was comparable between patients. 
 
ET: embryo transfer, OPU: oocyte pick-up or oocyte retrieval.  
Fig. 1. Stimulation protocol in a GnRH antagonist/rec-FSH IVF cycle. The day of oocyte 
retrieval in a stimulated cycle is analogous to the day of ovulation in a natural cycle. 
2.3 Human uterine tissue collection 
Endometrial biopsies were taken with a pipelle (Pipelle de Cornier®, Prodimed, Neuilly-en- 
Thelle, France) under sterile conditions on the day of oocyte retrieval. The biopsies were 
divided into two parts. One part of the endometrial tissue was used for classical histological 
analysis with haematoxylin and eosin staining. Endometrial dating was performed on all 
samples according to the criteria of Noyes (Noyes et al., 1950) by a pathologist, blinded for 
clinical outcome. The other part was snap-frozen in liquid nitrogen under sterile conditions 
for further RNA isolation and gene expression analysis with microarray technology, 
followed by validation with a more quantitative PCR.  
2.4 Gene expression profiling 
RNA extraction was performed using the RNeasy Mini kit (Qiagen, Valencia, CA, USA). 
Total RNA concentration was measured with the NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE, USA) and integrity of the RNA samples was 
controlled using the Agilent 2100 Bioanalyzer with the RNA 6000 Nano Kit (Agilent 
Technologies Inc., Palo Alto, CA, USA). 
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The human genome encodes for approximately 25 000 genes, however only a subset is active 
or expressed in any cell and the levels and timing of RNA expression regulate cellular 
development, differentiation and function. Microarrays are a tool to make a snapshot of the 
gene expression situation in a cell or tissue at a particular moment. 
For the gene expression analysis, 2 μg of the total amount of isolated RNA was reverse 
transcribed with the SuperScript Choice System (Invitrogen, Carlsbad, CA, USA) with oligo-
dT primers containing a T7 RNA polymerase promotor site (Figure 2). Then, cDNA was in 
vitro transcribed and labelled with biotin using the IVT labelling kit (Affymetrix, Santa 
Clara, CA, USA) followed by the fragmentation of the biotinylated cRNA. The fragmented 
cRNA was hybridized overnight to the Affymetrix Human Genome (HG) U133 Plus 2.0 
Array (Affymetrix). This array contains more than 54 000 probe sets. Each probe set is 
designed to detect one specific gene or transcript. The microarray contains a redundant 
number of probe sets. A gene can be represented by 2 or even more than 10 probe sets. This 
means that about 54 000 probe sets on the Affymetrix HG U133 Plus 2.0 Array cover the 
whole human genome of about 20 000-30 000 genes. 
 
Fig. 2. Microarray work flow. Attributed to The Science Creative Quarterly (scq.ubc.ca).   
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2.5 Data analysis 
2.5.1 Significant differential expression 
Affymetrix GeneChip Operating Software (GCOS) version 1.4 with the MAS 5.0 algorithm 
was used to analyse the resulting image files. Transcripts were considered as differentially 
expressed when the following criteria were met: (i) present (P) ‘calls’ in all samples of the 
selected group; (ii) consistent (minimum in 2/3 of the comparisons) decreased or increased 
change in expression for pair-wise comparisons between the two selected groups; (iii) a 
mean absolute value of the signal log ratio (SLR) ≥ 0.5; this equals a fold change ratio (FC) of 
1.4 or higher and (iv) a two-tailed unpaired Student’s t-test with a significant result (P ≤ 
0.05). The data files have been deposited in NCBI’s public database Gene Expression 
Omnibus (GEO) according to MIAME (Minimum Information About a Microarray 
Experiment) guidelines. 
2.5.2 PCA and clustering 
Principal component analysis (PCA) and hierarchical clustering was performed in an 
unsupervised way with GeneSpring GX software (Agilent Technologies). Principal component 
analysis is mainly used to visually assess the quality of replicate samples. Each point in the 3D 
plot represents a sample. With multiple replicates in each group, the replicates should be 
grouped together. If any of the biological replicates mix with another group, this sample may 
be further examined. PCA is a tool to visualize multidimensional data, like microarray data, 
into two or three dimensions. Each dimension represents a principal component (PC) with a 
certain percentage of variance. The percentage of variation is captured along three axes with 
the first axis (PCA 1) having the largest percentage of variation. 
Hierarchical cluster analysis is a statistical method to group samples unsupervised in different 
clusters or branches of the hierarchical or condition tree. In this way, the relationships between 
the different groups are shown (Eisen et al., 1998). The condition tree can be displayed as a so-
called ‘heat map’, based on the measured expression levels of the probe sets. 
2.5.3 Network and pathway analysis 
Further gene ontology study was performed with Ingenuity Pathways Analysis (IPA) 
software (Ingenuity® Systems, www.ingenuity.com, Redwood City, CA, USA) for further 
network and pathway analysis. A data file was uploaded that contained the gene identifiers 
for the differentially expressed probe sets and the corresponding expression values. Each 
gene identifier was mapped to its corresponding gene (object) in the Ingenuity Pathways 
Knowledge Base (IPKB). A log ratio threshold of 0.5 was set to identify focus genes whose 
expression was significantly differentially regulated. Networks of these genes were then 
algorithmically generated based on their connectivity in the IPKB. The networks were 
assigned a score, according to their relevance to the list of focus genes. Each network was 
arbitrarily set to have a maximum of 35 focus genes. Networks are shown as nodes and 
lines: nodes represent genes and lines represent the relationships between the genes (see 
Figure 4 in the Results section). All lines are supported by at least one reference from the 
literature. The intensity of the node colour indicates the degree of up- (red) or down- (green) 
regulation. Nodes are displayed using various shapes representing the functional class of 
the gene product (see legend Figure 4).  
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The functional analysis identified the biological functions and/or diseases that were most 
significant to the data set (see Figure 5). Genes from the data set that met the P-value 
threshold of 0.05 (Fisher’s exact test) and were associated with biological functions and/or 
diseases in the IPKB were considered for the analysis.  
Canonical pathway analysis (see Figure 6) identified the pathways most significant to the 
data set, based on two parameters: (i) a ratio of the number of genes from the data set that 
map to the pathway divided by the total number of genes that map to the canonical 
pathway; (ii) Fisher’s exact test was used to calculate a P-value determining the probability 
that the association between the genes in the dataset and the canonical pathway is explained 
by chance alone (www.ingenuity.com/company/pdf/Citation_Guidelines_2005-09-13.pdf). 
2.6 QPCR validation 
Quantitative validation was performed with QPCR for selected genes. Genes were selected for 
validation by quantitative real-time PCR (QPCR) because of their highly significant p-value or 
fold change ratio (FC) and/or because more than one probe set for the same gene was 
significantly differentially expressed. The selection also occurred on the available literature. 
A two-step real-time PCR was performed. A reverse-transcription reaction from total RNA 
was achieved with the High-Capacity cDNA Archive kit (Applied Biosystems, Foster City, 
CA, USA) following the manufacturer’s protocol. The quantitative real-time PCR was 
performed with the TaqMan Gene Expression Assay (Applied Biosystems), containing two 
unlabeled primers and one TaqMan FAM dye-labelled MGB (‘minor groove binding’) 
probe. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was chosen as the control 
housekeeping gene using the TaqMan Endogenous Control Assay (Applied Biosystems) 
containing two unlabeled primers and one TaqMan FAM dye-labelled MGB probe. Both 
assays are cDNA specific, since the probes span an exon junction.  
All real-time PCR assays were run using the TaqMan Universal PCR Master Mix plus 
AmpErase UNG (Applied Biosystems) on the 7900 HT Fast System (Applied Biosystems). 
Thermal cycling parameters were set as follows: 2 min. at 50°C (AmpErase UNG activation), 
10 min. at 95°C (AmpliTaq Gold activation), followed by 40 cycles of denaturation, 
annealing and extension (15 sec. at 95°C and 1 min. at 60°C, respectively). No-template and 
no-RT (reverse transcriptase) controls were included to verify the quality and cDNA 
specificity of the primers. All samples were analysed in triplicate. The relative quantification 
was performed by the standard curve method. For each sample, the amount of target gene 
and endogenous control (GAPDH) was determined from their respective standard curves. 
First, the target gene amount was divided by the endogenous control amount to obtain a 
normalized value. In a second step, the samples were normalized again to the sample with 
the lowest normalized expression, the calibrator sample or 1x sample. Therefore, each of the 
normalized values was divided by the calibrator normalized value to generate the relative 
expression levels. Significance was achieved when p < 0.05 (with t-test). 
3. Results 
3.1 Patient groups 
The endometrial gene expression profile on the day of oocyte retrieval in rec-FSH stimulated 
GnRH-antagonist cycles for IVF with embryo transfer in the same cycle was studied and 
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correlated with the serum P concentration on the day of hCG administration (Van 
Vaerenbergh et al., 2011). Three groups of patients (n= 14 in total) with different serum P 
concentrations on the day of hCG were analysed: a group with P below 0.9 ng/ml, an 
intermediate group with P from 1 to 1.5 ng/ml and a high concentration group with P above 
1.5 ng/ml. These cut-offs were based on the recent literature (Papanikolaou et al., 2009; 
Venetis et al., 2007). In these articles, 0.9 ng/ml was found as the lowest threshold for P 
concentration and 1.5 ng/ml was found as the highest threshold. Although different cut-offs 
have been used over the years ranging from 0.8 to even 2 ng/ml (Hofmann et al., 1993; 
Ubaldi et al., 1996; Silverberg et al., 1994; Edelstein et al., 1990; Givens et al., 1994), in recent 
publications the upper cut-off level is set at 1.5 ng/ml. 
In these three groups of patients, the patients with a clinical pregnancy (defined according 
to ICMART/WHO terminology, as a pregnancy diagnosed by ultrasonographic 
visualization of one or more gestational sacs or definitive clinical signs of pregnancy; 
Zegers-Hochschild et al., 2009) were observed in the low and intermediate group. No 
clinical pregnancies occurred when the P concentration on the day of hCG administration 
was above 1.5 ng/ml. 
Histological dating demonstrated an advanced secretory endometrial maturation for the 
majority of patients (13 out of 14 or 92.8%), ranging from +day 2 (two days advanced as 
compared to the chronological cycle day, which is the day of oocyte retrieval, considered as 
day 0)  to +day 4. 
3.2 Gene expression 
In the comparison between 3 groups, a small difference in gene expression between the first 
two groups was found. However, the gene expression profile from patients with high P 
concentration (> 1.5 ng/ml) was significantly different from the patients in the other two 
groups. These results were also confirmed with principal component analysis and 
hierarchical clustering, where a separate cluster for patients with high P concentration (> 1.5 
ng/ml) was found (Figure 3a and 3b). In this way, the threshold of 1.5 ng/ml, as suggested 
in recent literature (Papanikolaou et al., 2009; Bosch et al., 2010), was confirmed at the 
molecular level.  
3.3 Validation with QPCR 
The results obtained with the microarray gene expression analysis have been validated for 
selected genes with a more quantitative real-time PCR technique. Some of the genes that 
were selected for validation had already known roles in the reproductive system. For 
example DKK3 (Dickkopf homolog 3) is a known molecule in the Wnt/ β catenin 
signalling pathway. Other genes that were selected for validation with QPCR were: 
PAPPA (pregnancy associated plasma protein A or pappalysin), PRSS23 (protease serine 
23), IL17RB (interleukin 17 receptor B), and THSD4 (thrombospondin type 1 domain 
containing 4). 
These genes all showed a significant fold change (compared between the intermediate P 
concentration group and the high concentration group) comparable with their fold changes 
obtained in the microarray experiment. 
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Fig. 3a. Principal component analysis (PCA) of 14 endometrial biopsies of patients with 
premature P rise on the day of hCG administration: low P concentration group (dark blue), 
an intermediate P concentration group (light blue) and high P concentration group (red). 
 
Fig. 3b. Hierarchical clustering analysis (condition tree) of the 14 endometrial samples, 
displayed as a heat map. Colour code: see legend figure 3a. 
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3.4 Pathway and network analysis 
The list of significantly differentially expressed probe sets (or genes) was further studied 
with Ingenuity to find the associated canonical pathways and to discover networks 
between the genes that can be formed based on the available literature. Biological 
functions that were most significant to the dataset were assigned. In total, 41 networks 
were derived from the gene list, from which 30 were made up of at least 13 focus 
molecules (Figure 4).  
 
 
Fig. 4. Network formed on the basis of the literature findings in the Ingenuity database. 
Upregulated genes from our dataset are coloured red, downregulated genes are coloured 
green. The shape of the nodes represents the type of molecule (for example enzyme, 
transcription regulator, group or complex). The lines represent the relationships between the 
genes (direct or indirect interaction). 
The functional analysis identified the biological functions that were most significant to the 
data set. The top functions were cancer, cellular growth and proliferation, genetic disorders, 
cellular movement and development and reproductive system diseases (Figure 5). 
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Fig. 5. Overview of the most relevant biological functions or diseases. 
Pathway analysis was performed as well (Figure 6). A significant canonical pathway 
associated with both SOX family members and DKK family members from our data set was 
the Wnt/ β catenin signalling pathway (Figure 7). This pathway is well known for its role in 
the reproductive system.  
 
Fig. 6. Overview of the most relevant canonical pathways associated with the data set. 
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Fig. 7. Wnt/β catenin signalling pathway, in which the DKK (Dickkopf) molecules are 
upregulated (coloured red) and the SOX family members are downregulated (coloured 
green), according to our data set. 
4. Discussion 
Some patients undergoing a stimulated IVF protocol experience premature progesterone 
elevation towards the end of the follicular phase. Currently, there is an ongoing debate (Van 
Vaerenbergh et al., 2011 Hum Rep; Al-Azemi et al., submitted to Hum Rep Update) about 
the aetiology of this premature progesterone rise. It is hypothesized this is due to the high 
response of the ovary to the stimulation protocol and is associated with lower clinical 
pregnancy rates (Kyrou et al., 2009: Papanikolaou et al., 2009). In other recent studies, the 
effect of higher progesterone levels on the endometrial receptivity has been studied as well 
on the RNA level (Labarta et al., 2011), and even on the microRNA level (Li et al., 2011).  
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In our study, several groups of patients with premature P rise were compared according to 
their serum P concentration on the day of hCG administration and in relationship with their 
gene expression profile on the day of oocyte retrieval. Several genes were selected out of the 
list of genes which were significantly differentially regulated between the groups with 1 ≤ P 
≤ 1.5 ng/ml and P > 1.5 ng/ml and confirmed with quantitative real-time PCR. The selection 
of genes occurred according to the criteria described above.  
Some of the selected genes were already known for their role(s) in reproductive processes.  
During each menstrual cycle, an extensive tissue remodelling process takes place. In the 
mammalian ovary, proteases are also required for remodelling of the extracellular matrix 
during follicular growth, breakdown of the follicular wall during ovulation, luteal formation 
and regression (Curry and Osteen, 2003; Ny et al., 2002). Up to date, several proteases have 
been implicated in the degradation of the extracellular matrix in the ovary as well as in the 
endometrium, such as MMPs (matrix metalloproteinases)/TIMPs (Tissue Inhibitor of 
Metalloproteinases) and ADAMTSs (A Disintegrin And Metalloproteinase with 
Thrombospondin Motifs).  
Protease, serine 23 or PRSS23 is an extracellular serine protease expressed in the mouse 
ovary and may play a role in follicular development in the mouse. PRSS23 is highly 
expressed in atretic follicles and in the ovarian stroma and thecal layers just before 
ovulation. Its dynamic expression pattern suggests that PRSS23 is involved in different 
tissue remodelling processes in the ovary, possibly by allowing extracellular matrix 
degradation and/or regulating growth factor availability (Miyakoshi et al., 2006; Wahlberg 
et al., 2008).  
THSD4 (thrombospondin, type I, domain containing 4) is an ADAMTS-like protein and has 
been described in human endometrium in a stimulated cycle in another study performed in 
the Centre for Reproductive Medicine (Blockeel et al., 2011).  
The interleukin 17 receptor B (IL17RB or IL17BR) is an estrogen-regulated gene (Wang et al., 
2007) and found to be a prognostic marker, together with homeobox 13 expression, for 
breast cancer (Jerevall et al., 2008; Ma et al., 2008). In general, interleukins, chemokines, 
cytokines and other immunological molecules are known to play a major role during 
implantation. (Lindhard et al., 2002). 
Another protease is PAPP-A or IGFBP4 (insulin-like growth factor-binding protein-4), a 
metalloproteinase from the metzincin superfamily (Boldt and Conover, 2007; Conover et al., 
2004; Ohnishi et al., 2005; Overgaard et al., 1999). This family also includes the astacins, 
serralysins, adamalysins (ADAMTS) and the matrix metalloproteinases (MMP) (Huxley-
Jones et al., 2007; Reiss et al., 2006). PAPP-A acts as a protease for IGFBP4 and in this way 
helps releasing IGF (insulin-like growth factor). IGF-II has a major role in implantation and 
trophoblast invasion (Giudice et al., 2002). Insuline-like growth factors can bind to six IGF-
binding proteins, IGFBP1-6, which are able to modulate IGF actions in various ways (Suzuki 
et al., 2006). PAPP-A is produced by the trophoblasts and also known as a sensitive marker 
for adverse pregnancy outcome in the first trimester (Suzuki et al., 2006). Human 
decidualized endometrial stromal cells secrete PAPP-A as well (Giudice et al., 2002). 
The Wnt/β-catenin signalling pathway has been described before in different implantation-
related and endometrial receptivity studies (Tulac et al., 2003; Van Vaerenbergh et al., 2009). 
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Furthermore, another member of the Dickkopf family, DKK1, has been observed in the mid-
secretory phase (LH+7) of a natural cycle in several endometrial receptivity gene expression 
studies (Carson et al., 2002; Haouzi et al., 2009; Riesewijk et al., 2003; Talbi et al., 2006). 
Previous studies (Kolibianakis et al., 2002; Ubaldi et al., 1997) with endometrial biopsies on 
the day of oocyte retrieval and following embryo transfer demonstrated that an endometrial 
advancement of more than 3 days never resulted in a clinical pregnancy. From an earlier 
study in our group (Van Vaerenbergh et al., 2009), these findings were confirmed on the 
gene expression level with microarrays. It was found that endometrial samples taken on the 
day of oocyte retrieval from patients in a GnRH antagonist/ rec-FSH stimulation protocol 
for IVF with embryo transfer all showed an advanced endometrial maturation and that the 
samples with an advanced endometrium of more than 3 days clustered together in a 
separate molecular profile. 
In this study, no clinical pregnancies were seen when the P concentration was higher than 
1.5 ng/ml. All four clinical pregnancies ensued in patients from groups with P  0.9 ng/ml 
and with 1  P  1.5 ng/ml. 
A large group of significantly differentially expressed probe sets was observed between the 
group with progesterone levels between 1 and 1.5 ng/ml (1  P  1.5 ng/ml) and the group 
with progesterone levels above 1.5 ng/ml. Moreover, hierarchical clustering analysis and 
principal component analysis showed a separate cluster for patients in the group with 
progesterone concentrations above 1.5 ng/ml. The clustering pattern possibly also reflects 
the state of endometrial maturation of the biopsy, as one sample dated as +day 4, is more 
closely situated near the cluster from the group with the highest progesterone 
concentrations. Although, there is a trend noticeable that patients with premature 
progesterone rise on the day of hCG administration have a morphological advanced 
secretory endometrium, this is not always true. In the current study, it can be demonstrated 
from the clustering analyses and the available histological dating results that the elevation of 
progesterone levels in the follicular phase seems somehow related to the endometrial 
maturation state, although predicting the histological date of the endometrial biopsy is not 
possible. 
5. Conclusion  
This is the first study to investigate the endometrial gene expression on the day of oocyte 
retrieval in stimulated cycles for IVF with embryo transfer, according to the concentration of 
progesterone on the day of hCG administration. 
In conclusion, the early elevation of progesterone on the day of hCG administration seems 
to have an instant effect on the endometrial gene expression, as shown by a biopsy sample 
taken only 36 hours later, on the day of oocyte retrieval. The threshold for P concentration 
with a distinct different molecular profile was found at 1.5 ng/ml. 
These significant changes observed at the gene expression level may explain the impairment 
of endometrial receptivity in the presence of elevated progesterone, reflected in the lower 
clinical pregnancy rates as reported in recent publications (Bosch et al., 2003; 2010; 
Kolibianakis et al., 2011).  
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